Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George E Fragoulis

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Clinical Rheumatology|December 15, 2019
Lung cancer in rheumatoid arthritis. Is there a need for better risk assessment and screening?George E Fragoulis, Katerina Chatzidionysiou
Best Practice & Research. Clinical Rheumatology|February 3, 2020
Established rheumatoid arthritis - Redefining the conceptKaterina Chatzidionysiou, George E Fragoulis
Musculoskeletal Care|September 7, 2022
The role of IL-23 and the use of IL-23 inhibitors in psoriatic arthritisGeorge E Fragoulis, Stefan Siebert
Therapeutic Advances in Musculoskeletal Disease|September 6, 2018
Inflammation, obesity and rheumatic disease: common mechanistic links. A narrative reviewElena Nikiphorou, George E Fragoulis
Clinical Rheumatology|December 13, 2022
JAK inhibitors, cardiovascular and thromboembolic events: what we know and what we would like to knowGerasimos Evangelatos, George E Fragoulis
Rheumatology (Oxford, England)|October 14, 2020
Treatment strategies in axial spondyloarthritis: what, when and how?George E Fragoulis, Stefan Siebert
Clinical Therapeutics|February 3, 2023
Comorbidities in Psoriatic Arthritis: A Narrative ReviewAlexandros Panagiotopoulos, George E Fragoulis
Clinical Rheumatology|May 18, 2021
Disease activity indices in psoriatic arthritis: current and evolving conceptsChrysoula G Gialouri, George E Fragoulis
Nature Clinical Practice. Rheumatology|May 29, 2008
Is mizoribine a new therapeutic agent for Sjögren's syndrome?Haralampos M Moutsopoulos, George E Fragoulis
Autoimmunity Reviews|October 30, 2020
Overview of IgG4-related aortitis and periaortitis. A decade since their first descriptionElena Nikiphorou, James Galloway, George E Fragoulis
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Clinical Rheumatology|December 15, 2019
Lung cancer in rheumatoid arthritis. Is there a need for better risk assessment and screening?George E Fragoulis, Katerina Chatzidionysiou
Best Practice & Research. Clinical Rheumatology|February 3, 2020
Established rheumatoid arthritis - Redefining the conceptKaterina Chatzidionysiou, George E Fragoulis
Musculoskeletal Care|September 7, 2022
The role of IL-23 and the use of IL-23 inhibitors in psoriatic arthritisGeorge E Fragoulis, Stefan Siebert
Therapeutic Advances in Musculoskeletal Disease|September 6, 2018
Inflammation, obesity and rheumatic disease: common mechanistic links. A narrative reviewElena Nikiphorou, George E Fragoulis
Clinical Rheumatology|December 13, 2022
JAK inhibitors, cardiovascular and thromboembolic events: what we know and what we would like to knowGerasimos Evangelatos, George E Fragoulis
Rheumatology (Oxford, England)|October 14, 2020
Treatment strategies in axial spondyloarthritis: what, when and how?George E Fragoulis, Stefan Siebert
Clinical Therapeutics|February 3, 2023
Comorbidities in Psoriatic Arthritis: A Narrative ReviewAlexandros Panagiotopoulos, George E Fragoulis
Clinical Rheumatology|May 18, 2021
Disease activity indices in psoriatic arthritis: current and evolving conceptsChrysoula G Gialouri, George E Fragoulis
Nature Clinical Practice. Rheumatology|May 29, 2008
Is mizoribine a new therapeutic agent for Sjögren's syndrome?Haralampos M Moutsopoulos, George E Fragoulis
Autoimmunity Reviews|October 30, 2020
Overview of IgG4-related aortitis and periaortitis. A decade since their first descriptionElena Nikiphorou, James Galloway, George E Fragoulis
Pageof 12